Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Objective To conduct a systematic review to determine the relative effectiveness of
treatments currently employed in the management of superior vena caval obstruction …

Background Many patients with lung cancer will develop symptoms related to their disease
process or the treatment they are receiving. These symptoms can be as debilitating as the …

Superior vena cava syndrome (SVCS) is a relatively common sequela of mediastinal
malignancies and may cause significant patient distress. SVCS is a medical emergency if …

Superior vena cava (SVC) syndrome has a characteristic and often striking clinical
presentation, which can occasionally be life threatening. It is caused by obstruction of the …

Goals/objectives To review the scientific evidence on symptoms and specific complications
that are associated with lung cancer, and the methods available to palliate those symptoms …

The superior vena cava syndrome (SVCS) is caused by compression, invasion, and/or
thrombosis of the superior vena cava and/or the brachiocephalic veins. Benign SVCS is …

Superior vena cava syndrome (SVCS) is a common complication of malignancy. The
epidemiology, presentation, and diagnostic evaluation of patients presenting with the …

Qualitätsindikatoren wurden durch Sens et al. wie folgt definiert:„Ein Indikator ist ein
quantitatives Maß, welches zum Monitoring und zur Bewertung der Qualität wichtiger …

Superior vena cava stenting for the treatment of malignant superior vena cava obstruction is
now well established. It offers simple, rapid, and safe palliation of a distressing and …